Breath methylated alkane contour: a new marker of oxidative stress and disease
US6254547A · kind A · utility
32Cited by
1References
2Claims
0Family size
Inventor
Key dates
| Filing date | Nov 8, 1999 |
| Grant date | Jul 3, 2001 |
| Priority date | — |
| Expiry date | Nov 8, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/90
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The alkane profile, comprising the alveolar gradients of n-alkanes in breath having 2 to 20 carbons, and the alveolar gradients of methylated C3-C20 alkanes, is determined for the diagnosis of disease in mammals, including humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.